MétaCan
Menu
Back to cohort
Record W4407044826 · doi:10.5853/jos.2024.03062

Thrombolysis in Patients With Versus Without Visible Occlusion: A Secondary Analysis From the AcT Trial

2025· article· en· W4407044826 on OpenAlexaffabout
A. Zohaib Siddiqi, Katrina Hannah D. Ignacio, Chitapa Kaveeta, Fouzi Bala, Ayoola Ademola, Aleksander Tkach, Brian Buck, Luciana Catanese, Gary Hunter, Dar Dowlatshahi, Michel Shamy, Atif Zafar, Thalia S. Field, Ramana Appireddy, Ankur Wadhwa, Tolulope T. Sajobi, Richard H. Swartz, Mohammed Almekhlafi, Andrew M. Demchuk, Bijoy K. Menon, Nishita Singh

Bibliographic record

VenueJournal of Stroke · 2025
Typearticle
Languageen
FieldMedicine
TopicAcute Ischemic Stroke Management
Canadian institutionsUniversity of TorontoQueen's UniversityUniversity of British ColumbiaSunnybrook Health Science CentreKelowna General HospitalSt. Michael's HospitalUniversity of OttawaMcMaster UniversityHotchkiss Brain InstituteHamilton Health SciencesHealth Sciences CentreOttawa HospitalUniversity of ManitobaOntario Brain InstituteUniversity of SaskatchewanUniversity of AlbertaUniversity of Calgary
Fundersnot available
KeywordsMedicineThrombolysisOcclusionInternal medicineCardiologyMyocardial infarction

Abstract

fetched live from OpenAlex

Approximately 70% of patients who present with symptoms of acute ischemic stroke (AIS) have no visible occlusion (NVO) on intracranial computed tomography angiography (CTA). 1 These patients may either have lacunar stroke, intracranial pial arterial occlusions that are not visible on CTA, vascular stenosis resulting in hypoperfusion, spontaneous recanalization, or conditions that are stroke mimics.Owing to these different mechanisms, current data on the safety and efficacy of intravenous thrombolysis in patients with NVO is conflicting.2,3 The aim of the current study, from the phase 3 Alteplase Compared to Tenecteplase in Patients With Acute Ischemic Stroke (AcT) randomized controlled trial, is to report on safety and efficacy outcomes in patients with NVO versus those with visible occlusion (VO) on baseline CTA who received thrombolysis.This sub-study is an exploratory analysis of the AcT trial, which randomized adult patients with stroke symptoms, eligible for intravenous thrombolysis as per guidelines, to either alteplase or tenecteplase.4,5 The trial was regulated by Health Canada and approved by research ethics boards at all participating sites.The trial used deferred consent procedures wherever approved by local research ethics boards.The current analysis included patients with interpretable baseline CT angiogram who received intravenous thrombolysis.An independent blinded imaging core lab with 4-20 years of experience read all imaging data.VO was defined as any occluded artery visualized on baseline CTA.NVO were those patients who did not have any intracranial occlusion on baseline CTA.Safety outcomes included symptomatic intracerebral hemorrhage (sICH) within 24 hours, mortality, and evidence of bleeding on follow-up imaging as per the Heidelberg Bleeding Classification described in the trial protocol 5 (Supplementary Methods).Functional outcomes included modified Rankin Scale (mRS) 6 0-1, mRS 0-2, ordinal mRS at 90-120 days, return

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.007
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.007
Threshold uncertainty score0.024

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0040.007
Meta-epidemiology (narrow)0.0020.000
Meta-epidemiology (broad)0.0030.005
Bibliometrics0.0010.001
Science and technology studies0.0000.001
Scholarly communication0.0020.001
Open science0.0010.001
Research integrity0.0010.003
Insufficient payload (model declined to judge)0.0070.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.009
GPT teacher head0.271
Teacher spread0.261 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueJournal of StrokeSame topicAcute Ischemic Stroke ManagementFrench-language works237,207